Peripheral mononuclear cell IL-10 and IL-12 production is not impaired in patients with advanced cancer and severe infection

Cytokine

Volumn 20, Issue 5, 2002, Pages 210-214

  Kallio, Raija ^a   Surcel, Heljä Marja ^a   Syrjälä, Hannu ^b  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Cancer; Infection; Interleukin 10; Interleukin 12; Monocytes

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CANCER STAGING; CELL STIMULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; FEMALE; HUMAN; HUMAN CELL; INFECTION; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; BIOSYNTHESIS; BLOOD; GENETICS; METABOLISM; MIDDLE AGED; NEOPLASM;

ACUTE DISEASE; ADULT; AGED; FEMALE; HUMANS; INFECTION; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEOPLASMS;

EID: 0041805492     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2002.2003     Document Type: Article

References (21)

1. Trinchieri G. Interleukin 12. Theze J. The cytokine network and immune functions. 1999;97-103 University Press Oxford, Oxford.
2. Hensler T., Heidecke C-L, Hecker H., Heeg K., Bartels H., Zantl N., Wagner H., Siewetr J-R, Holzmann B. Increased susceptibility to postoperative sepsis in patients with impaired monocyte IL-12 production. J Immunol. 161:1998;2655-2659.
3. Pretolani M., Stordeur P., Goldman M. Interleukin 10. Theze J. The cytokine network and immune function. 1999;45-50 Oxford University Press, Oxford.
4. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 174:1991;1209-1220.
5. Chen L., Linsley P., Hellström K. Costimulation of T cells for tumor immunity. Immunol Today. 14:1993;483-486.
6. Gimmi C.D., Freeman G.J., Gribben J.G., Gray G., Nadler L.M. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. P Natl Acad Sci USA. 90:1993;6586-6590.
7. Restifo N.P., Esquivel F., Kawakami Y., Yewdell J.W., Mule J.J., Rosenberg S.A., Bennink J.R. Identification of human cancers deficient in antigen processing. J Exp Med. 177:1993;265-272.
8. Munoz C., Carlet J., Fitting C., Misset B., Bleriot J-P, Cavaillon J-M. Dysregulation of in vitro cytokine production by monocyte during sepsis. J Clin Invest. 88:1991;1747-1754.
9. Sfeir T., Saha D.C., Astiz M., Rackow E. Role of interleukin-10 in monocyte hyporesponsiveness associated with septic shock. Crit Care Med. 29:2001;129-133.
10. Kallio R., Surcel H-M, Bloigu A., Syrjälä H. Balance between interleukin-10 and interleukin-12 in adult cancer patients with or without infections. Eur J Cancer. 37:2001;857-861.
11. Surcel H-M, Sarvas M., Helander I.M., Herva E. Membrane proteins of Francisella tularensis LVS differ in ability to induce proliferation of lymphocytes from tularemia-vaccinated individuals. Microbial pathogenesis. 7:1989;411-419.
12. Weighardt H., Heidecke C-D, Westerholt A., Westerholt A., Emmanuilidis K., Maier S., Veit M., Gerauer K., Matevossian E., Ulm K., Siewert J.R., Holzmann B. Impaired monocyte IL-12 production before surgery as a predictive factor for the lethal outcome of postoperative sepsis. Ann Surg. 235:2002;560-567.
13. de Bont ESJM, Kimpen J.L.L., Tamminga R.Y.J., Niemarkt A.E., de Leij LHMF, Kamps W.A. Intrinsic capacity of monocyte to produce cytokines ex vivo in patients with acute lymphoblastic leukaemia. Cytokine. 12:2000;1723-1726.
14. Fortis C., Foppoli M., Gianotti L., Galli L., Citterio G., Gentilini O., Braga M. Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett. 104:1996;1-5.
15. Avradopoulos K., Mehta S., Blackinton D., Wanebo H.J. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol. 4:1997;184-190.
16. De Vita F., Orditura M., Galizia G., Romano C., Infusino S., Auriemma A., Lieto E., Catalano G. Serum interleukin10 levels in patients with advanced gastrointestinal malignancies. Cancer. 86:1999;1936-1943.
17. Wojciechowska-Lacka A., Matecka-Nowak M., Adamiak E., Lacki J., Cerkaska-Gluszak B. Serum levels of interleukin-10 and interleukin-6 in patients with lung cancer. Neoplasma. 43:1999;155-158.
18. Gallizia G., Lieto E., de Vita F., Romano C., Castellano P., Imperatore V., Infusino S., Catalano G., Pignatelli C. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome. Interferon Cytokine Res. 22:2002;473-482.
19. Glauser M.P., Zanetti J-D, Baumgartner J.D., Cohen J. Septic shock: pathogenesis. Lancet. 338:1991;732-736.
20. Bone R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med. 24:1996;163-172.
21. Heumann D., Glauser M.P., Calandra T. Monocyte deactivation in septic shock. Current Opin Infect Dis. 11:1998;279-283.